Teva Pharmaceutical Industries Limited American Depositary Shares
TEVADividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 12, 2017 | $0.09 | 2017-11-27 | 2017-11-28 |
| September 14, 2017 | $0.09 | 2017-08-25 | 2017-08-29 |
| June 22, 2017 | $0.34 | 2017-06-01 | 2017-06-05 |
| March 20, 2017 | $0.34 | 2017-02-28 | 2017-03-02 |
| December 20, 2016 | $0.34 | 2016-12-01 | 2016-12-05 |
Dividends Summary
- Teva Pharmaceutical Industries Limited American Depositary Shares has issued 58 dividend payments over the past 14 years
- The most recent dividend was paid 2930 days ago, on December 12, 2017
- The highest dividend payed out to investors during this period was $0.35 per share
- The average dividend paid during this period was $0.20 per share.
Company News
Teva Pharmaceutical is a generic drug company transitioning to more complex generics and developing proprietary branded drugs, which introduces new growth opportunities and risks for investors.
Over 20 pharmaceutical companies are developing new treatments for celiac disease, moving beyond the current gluten-free diet management approach. Clinical trials are exploring innovative therapies targeting various mechanisms to improve patient outcomes.
The Trump administration will exclude imported generic drugs from potential tariffs, bringing relief to pharmaceutical companies and Indian drugmakers who supply nearly half of U.S. generic prescriptions.
AbbVie's (ABBV) acquisition of Celsius Therapeutics is set to add the latter's lead pipeline candidate, CEL383, a potential first-in-class TREM1 inhibitor, to ABBV's pipeline.
